NCT05249166 (ALINFA) is a NA clinical trial of ALINFA in Healthy Children, sponsored by Clinica Universidad de Navarra, Universidad de Navarra.

Who is sponsoring NCT05249166?

NCT05249166 is sponsored by Clinica Universidad de Navarra, Universidad de Navarra.

What drugs are being tested in NCT05249166?

Interventions in NCT05249166: ALINFA, Control.

What condition does NCT05249166 study?

NCT05249166 studies Healthy Children.

Is NCT05249166 still recruiting?

NCT05249166 is currently completed. Last updated 21 February 2022.

Last reviewed 2022-02-21 · How we verify

NCT05249166: ALINFA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Feeding for Accesible, Affordable and Healthy Childhood

Completed NA Last updated 21 February 2022

What this trial tests

NA trial testing ALINFA in Healthy Children in 70 participants. Completed in 10 December 2021.

Timeline

15 March 2021

Primary endpoint
10 December 2021

10 December 2021

Quick facts

Lead sponsor	Clinica Universidad de Navarra, Universidad de Navarra
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	70
Start date	15 March 2021
Primary completion	10 December 2021
Estimated completion	10 December 2021
Sites	1 location across Spain

Drugs / interventions tested

ALINFA
Control

Conditions studied

Healthy Children — all drugs for Healthy Children →

Sponsor

Clinica Universidad de Navarra, Universidad de Navarra

Who can join

Adults 6 to 12, any sex, with Healthy Children. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of this study was to evaluate the effectiveness of implementing a healthy eating vs traditional recommendations on the Medkid index of children in primary school. To do so, different companies involved in ALINFA project developed with the assessment of UNAV, CNTA and UPNA, a healthy bi-weekly menu.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

The ALINFA Intervention Improves Diet Quality and Nutritional Status in Children 6 to 12 Years Old.
Andueza N, Martin-Calvo N, Navas-Carretero S, Cuervo M. · · 2023 · cited 8× · PMID 37242258 · DOI 10.3390/nu15102375
Changes in urinary metabolomic profile show the effectiveness of a nutritional intervention in children 6-12 years old: The ALINFA study.
Andueza N, Muñoz-Prieto D, Romo-Hualde A, Cuervo M, et al · · 2024 · PMID 39139943 · DOI 10.1002/fsn3.4226
A Higher Adherence to the ALINFA Nutritional Intervention Is Effective for Improving Dietary Patterns in Children.
Vázquez-Bolea N, Andueza N, Cuervo M, Navas-Carretero S. · · 2024 · PMID 38790554 · DOI 10.3390/children11050559

Verify or expand the search:

Other recruiting trials for Healthy Children

Currently open trials in the same condition.

NCT06986720 — Urdu Translation of Revised High-Level Mobility Assessment Tool (HiMAT) in Healthy Children · recruiting
NCT07005440 — Functional Training and Dynamic Play Exercise on Gross Motor Skills, Physical Fitness, and Balance in Healthy Children · NA · recruiting
NCT06975982 — Symptoms, Pulmonary Function, Muscle Strength, Exercise Capacity, and Frailty in Esophageal Atresia vs. Healthy Peers · recruiting
NCT06276426 — Plants Optimizing Development Study (PODS) · NA · recruiting
NCT07490587 — To Investigate the Effects of Bifidobacterium Animalis Subsp. Lactis XLTG11 on Growth and Development, Incidence of Alle · Phase 2 · recruiting

Other Clinica Universidad de Navarra, Universidad de Navarra trials

Trials by the same sponsor.

NCT07370571 — NO AXILLARY SURGERY IN EARLY BREAST CANCER (OXIGENATE) · not yet recruiting
NCT07165431 — Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2). · NA · recruiting
NCT07447440 — Role of Pro-Resolving Lipid Mediators in Obesity-Associated Diseases · recruiting
NCT07191210 — Co-Designed Comprehensive Transition Programme for First-Line Nurse Managers · NA · not yet recruiting
NCT07132060 — MRI-guided Dose Intensification Program Locally Advanced Pancreatic Cancer · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05249166 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Clinica Universidad de Navarra, Universidad de Navarra
Last refreshed: 21 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05249166.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing